FOSAPREPITANT DIMEGLUMINE
Active substance: fosaprepitant dimeglumine
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · FOSAPREPITANT DIMEGLUMINE 150 mg/5mL
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FOSAPREPITANT DIMEGLUMINE · 150 mg/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4fd9-70d2-8a86-27dadae7d41d,01a1208c-58fc-7398-ac99-4e193f5e7ba0,01a1208c-b43d-78a4-9e11-912c44c4757f,01a1208d-1bc6-783b-962e-13ac813d4aab,01a1208d-d99c-70f8-8afe-e64035b526d6;count=27 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0143-9384
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0143-9384 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9384 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9384 · Verified 2026-10-09 · open in source